Departed
Michael Mardy
Director
LVLU ·
Lulu's Fashion Lounge Holdings, Inc.
Michael Mardy tendered his resignation as a Class III director of the Board
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7601–7650 of 35180
Michael Mardy tendered his resignation as a Class III director of the Board
On August 29, 2024, Winston Ma resigned as a director of MCAA.
On September 3, 2024, the Board of Directors (the “Board”) of General Motors Company (“GM”) elected Alfred F. Kelly, Jr. as a member of the Board.
On September 3, 2024, the board of directors of Lantheus Holdings, Inc. (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Julie Eastland, an experienced biotechnology and financial executive, to the Board.
On September 3, 2024, the board of directors (the “Board”) of J.Jill, Inc. (the “Company”) increased the size of the Board from seven to eight directors and appointed Courtnee Chun to serve as a Class I director of the Company, effective immediately.
each of Kevin DeNuccio and Said Ouissal notified the board of directors (the “Board”) of MARA Holdings, Inc. (the “Company”) of his decision to resign from the Board, effective as of September 1, 2024
each of Kevin DeNuccio and Said Ouissal notified the board of directors (the “Board”) of MARA Holdings, Inc. (the “Company”) of his decision to resign from the Board, effective as of September 1, 2024
the Board appointed each of Janet George and Barbara Humpton to serve as a director on the Board, filling the vacancies created by the aforementioned resignations, effective immediately.
the Board appointed each of Janet George and Barbara Humpton to serve as a director on the Board, filling the vacancies created by the aforementioned resignations, effective immediately.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
At the Effective Time, the following persons became directors of the Company: Louis Maiuri, Gary Zyla and Michael Lomio.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
At the Effective Time, the following persons became directors of the Company: Louis Maiuri, Gary Zyla and Michael Lomio.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
At the Effective Time, the following persons became directors of the Company: Louis Maiuri, Gary Zyla and Michael Lomio.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
appointed Mr. Sivaramakichenane Somasegar as a director of the Company to fill the resulting vacancy, effective September 5, 2024.
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
the Company’s Board of Directors appointed Gary Herman as a Class I Director and Marc Seelenfreund and Avtar Dhaliwal as Class II directors.
the Company’s Board of Directors appointed Gary Herman as a Class I Director and Marc Seelenfreund and Avtar Dhaliwal as Class II directors.
the Company’s Board of Directors appointed Gary Herman as a Class I Director and Marc Seelenfreund and Avtar Dhaliwal as Class II directors.
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
On September 2, 2024, Edward J. Fitzgerald notified EQT Exeter Real Estate Income Trust, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors (the “Board”) and as Chairman of the Board effective immediately.
Effective September 4, 2024, the Board of Directors (the “Board”) of United Community Banks, Inc. (the “Company”) appointed Sally Pope Davis to serve as a Board member
appointed Ms. Patrice Douglas as a director of Noble, effective as of immediately following the Effective Time.
elected Colin Wilson to join the Board of the Company, effective immediately, filling a vacancy.
the Board, upon the recommendation of the Governance and Nominating Committee of the Board (the "Governance and Nominating Committee"), reduced the size of the Board from nine to eight members and appointed Fred Hassan to fill the remaining vacancy on the Board.
On September 3, 2024, David R. Guyer, M.D. and Anthony P. Adamis, M.D. resigned from the Board of Directors (the "Board") of EyePoint Pharmaceuticals, Inc. (the "Company") and all committees thereof, effective immediately.
On September 3, 2024, David R. Guyer, M.D. and Anthony P. Adamis, M.D. resigned from the Board of Directors (the "Board") of EyePoint Pharmaceuticals, Inc. (the "Company") and all committees thereof, effective immediately.
On September 2, 2024, the Board of Directors (the "Board") of Allurion Technologies, Inc. ("Allurion" or the "Company") appointed Keith Johns to the Board as a Class III director to fill a vacancy created by an increase in the size of the Board from seven members to eight members, effective September 2, 2024.
the Board of Directors (the “ Board ”) of Milestone Pharmaceuticals Inc. (the “ Company ”), upon the recommendation of the Nominating & Corporate Governance Committee of the Board, voted to elect Joeseph C. Papa as a member of the Board and as a member of the Board’s compensation committee (the “ Compensation Committee ”), effective as of September 3, 2024
On September 3, 2024, Brent Handler, a member of the Board of Directors of Inspirato Incorporated (the "Company"), notified the Company of his intention to resign from the Company's Board of Directors, effective September 3, 2024.
At the Effective Time, Richard Barker, Jennie Howard and Craig Muirhead became the directors of Merger Sub 2, as the surviving entity in the Second Merger, and Mr. Barker became President, Ms. Howard became Secretary and Mr. Muirhead became Treasurer of Merger Sub 2, as the surviving entity in the Second Merger.
At the Effective Time, Richard Barker, Jennie Howard and Craig Muirhead became the directors of Merger Sub 2, as the surviving entity in the Second Merger, and Mr. Barker became President, Ms. Howard became Secretary and Mr. Muirhead became Treasurer of Merger Sub 2, as the surviving entity in the Second Merger.
At the Effective Time, Richard Barker, Jennie Howard and Craig Muirhead became the directors of Merger Sub 2, as the surviving entity in the Second Merger, and Mr. Barker became President, Ms. Howard became Secretary and Mr. Muirhead became Treasurer of Merger Sub 2, as the surviving entity in the Second Merger.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
Effective September 3, 2024, the Board appointed Jakob Dupont, M.D., Ph.D., to serve as a Class II member of the Board.
On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.
On August 28, 2024, James Healy, M.D., Ph.D., notified Bolt Biotherapeutics, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and the committees thereof, effective as of September 3, 2024.
On August 29, 2024, the Board of Directors (the "Board") of Kentucky First Federal Bancorp (the "Company") appointed R. Clay Hulette as a director of the Company, effective August 29, 2024, for an initial term expiring at the 2024 annual meeting of stockholders or until his successor shall have been duly elected and qualified.
Mr. Hulette's appointment will fill the vacancy created by the recent retirement of Tony D. Whitaker from the Board of Directors of the Company.
On August 28, 2024, Mr. Matthew Barger notified iLearningEngines, Inc. (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”) and all committees thereof.
the Board appointed Tom Miller, Ph.D., and Brent Shafer to serve as directors of the Company, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.